HuGE Literature Finder
Records
1
-
30
| Association of CYP2C19, TNF-a, NOD1, NOD2, and PPAR? polymorphisms with peptic ulcer disease enhanced by Helicobacter pylori infection. Saudi medical journal 2021 Jan 42 (1): 21-29. Al-Eitan Laith N, Almomani Fouad A, Al-Khatib Sohaib |
| Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PloS one 2021 16 (1): e0245401. Arévalo-Galvis Azucena, Otero-Regino William A, Ovalle-Celis Gloria N, Rodríguez-Gómez Eliana R, Trespalacios-Rangel Alba |
| Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine. Pharmacogenomics and personalized medicine 2020 13 1-12. Chamnanphon Monpat, Gaedigk Andrea, Puangpetch Apichaya, Pasomsub Ekawat, Chantratita Wasun, Longley Rhea J, Sattabongkot Jetsumon, Chariyavilaskul Pajaree, Sukasem Chonlaph |
| Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International journal of environmental research and public health 2019 Dec 17 (1): . Yu Ya-Yen, Tsao Shih-Ming, Yang Wen-Ta, Huang Wei-Chang, Lin Ching-Hsiung, Chen Wei-Wen, Yang Shun-Fa, Chiou Hui-Ling, Huang Yi-W |
| Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy. Helicobacter 2019 Mar e12574. Arévalo Galvis Azucena, Trespalacios Rangel Alba Alicia, Otero Regino Willi |
| CYP2C19*2 polymorphism in Polish peptic ulcer patients. Pharmacological reports : PR 2018 Dec 71 (2): 272-275. Salagacka-Kubiak Aleksandra, Zebrowska-Nawrocka Marta, Jelen Agnieszka, Mirowski Marek, Balcerczak E |
| Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes. Therapeutic drug monitoring 2017 Aug . Niioka Takenori, Fujishima Naohito, Abumiya Maiko, Yamashita Takaya, Ubukawa Kumi, Nara Miho, Fujishima Masumi, Takahashi Naoto, Miura Masato |
| Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study. Journal of digestive diseases 2016 Aug . Chwiesko Adam, Charkiewicz Radoslaw, Niklinski Jacek, Luczaj Wojciech, Skrzydlewska Elzbieta, Milewski Robert, Baniukiewicz Andrzej, Wroblewski Eugeniusz, Rosolowski Mariusz, Dabrowski Andrz |
| Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes. Pharmacogenomics 2016 Feb . Schirmer Jan Henrik, Bremer Jan Phillip, Moosig Frank, Holle Julia Ulrike, Lamprecht Peter, Wieczorek Stefan, Haenisch Sierk, Cascorbi Ingo |
| A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis. Drug metabolism and pharmacokinetics 2016 Jan . Sumonrat Chuwongwattana, Jantararoungtong Thawinee, Chitasombat Maria N, Puangpetch Apichaya, Prommas Santirat, Dilokpattanamongkol Pitchaya, Watcharananan Siriorn P, Sukasem Chonlaph |
| Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert review of gastroenterology & hepatology 2015 Oct 1-13. Miftahussurur Muhammad, Yamaoka Yosh |
| CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand. Asian Pacific journal of cancer prevention : APJCP 2015 16 (8): 3253-6. Nun-Anan Pongjarat, Chonprasertsuk Soonthorn, Siramolpiwat Sith, Tangaroonsanti Anupong, Bhanthumkomol Patommatat, Pornthisarn Bubpha, Vilaichone Ratha-Ko |
| Individuals having variant genotypes of cytochrome P450 2C19 are at increased risk of developing primary liver cancer in Han populations, without infection with the hepatitis virus. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Sep 35 (9): 9023-6. Li Qiao-Yan, Zhao Ning-Min, Wang Lian-Cai, Duan Hong-Fei, Ma Yong-Cheng, Zhang Wei, Zhao Hong-Wei, Qin Yu-H |
| Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine. Journal of clinical pharmacology 2014 Aug 54 (8): 858-64. Uotani Takahiro, Sugimoto Mitsushige, Nishino Masafumi, Ichikawa Hitomi, Sahara Shu, Yamade Mihoko, Iwaizumi Moriya, Yamada Takanori, Osawa Satoshi, Sugimoto Ken, Umemura Kazuo, Watanabe Hiroshi, Miyajima Hiroaki, Furuta Takahi |
| Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2014 Jul 33 (4): 330-5. Settin Ahmad, Abdalla Ahmad Fathy, Al-Hussaini Ayman S, El-Baz Rizk, Galal A |
| Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10957-60. Jainan Wannapa, Vilaichone Ratha-Ko |
| Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children. The Journal of pediatrics 2013 Sep 163 (3): 686-91. Lima John J, Lang Jason E, Mougey Edward B, Blake Kathryn B, Gong Yan, Holbrook Janet T, Wise Robert A, Teague W |
| CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. Clinical pharmacology and therapeutics 2012 Oct . Musumba CO, Jorgensen A, Sutton L, Van Eker D, Zhang E, O'Hara N, Carr DF, Pritchard DM, Pirmohamed M |
| Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis. The Indian journal of medical research 2012 May 135 (5): 642-9. Feng Wei-Xing, Liu Fang, Gu Yi, Jiao Wei-Wei, Sun Lin, Xiao Jing, Wu Xi-Rong, Miao Qing, Shen Chen, Shen Dan, Shen Ado |
| Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. Pharmacotherapy 2011 Mar 31 (3): 227-38. Yang Jyh-Chin, Wang Hong-Long, Chern Herng-Der, Shun Chia-Tung, Lin Bor-Ru, Lin Chun-Jung, Wang Teh-Ho |
| Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Alimentary pharmacology & therapeutics 2011 Jan 33 (2): 213-24. Kinoshita Y, Ashida K, Hongo M, |
| Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults. Clinical therapeutics 2010 Nov 32 (12): 2003-11. Pan Xiaolin, Li Yuqing, Qiu Yuping, Tang Qiyun, Qian Bingbing, Yao Linhua, Shi Ruihua, Zhang Guox |
| Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy. Helicobacter 2010 Aug 15 (4): 265-72. Kuo Chao-Hung, Wang Sophie S W, Hsu Wen-Hung, Kuo Fu-Chen, Weng Bi-Chuang, Li Chia-Jung, Hsu Ping-I, Chen Angela, Hung Wen-Chun, Yang Yuan-Chieh, Wang Wen-Ming, Wu Deng-Chya |
| Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole. European journal of clinical pharmacology 2010 Jul 66 (7): 681-7. Gawro?ska-Szklarz Barbara, Siuda Andrzej, Kurzawski Mateusz, Bielicki Dariusz, Marlicz Wojciech, Dro?dzik Mar |
| Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. Journal of clinical pharmacy and therapeutics 2010 Jun 35 (3): 343-50. Lee V W Y, Chau T S, Chan A K W, Lee K K C, Waye M M Y, Ling T K W, Chan F K |
| Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer. Journal of the Chinese Medical Association : JCMA 2010 Apr 73 (4): 188-93. Lay Chii-Shyan, Lin Chun-Jung, Lin Jiun-Ro |
| Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. Journal of gastroenterology and hepatology 2009 Nov 24 (11): 1725-32. Sugimoto Mitsushige, Furuta Takahisa, Yamaoka Yosh |
| Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori. British journal of clinical pharmacology 2009 May 67 (5): 503-10. Yang Jyh-Chin, Yang Yu-Fan, Uang Yow-Shieng, Lin Chun-Jung, Wang Teh-Ho |
| [Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection]. ?ksperimental'nai?a i klinicheskai?a gastro?nterologii?a = Experimental & clinical gastroenterology 2009 (4): 128-32. Kucheriavy? Iu |
| [Study of gene polymorphism responsible for metabolism of proton pump inhibitors in children with H. pylori infection: is there a correlation with efficacy of eradication treatment?]. ?ksperimental'nai?a i klinicheskai?a gastro?nterologii?a = Experimental & clinical gastroenterology 2009 (3): 101-4. Nizhevich A A, Iunusbaev B B, Tu?gunov M M, Tsiglintseva N P, Nasretdinova E |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: